Introduction
Cyclin Y is a recently characterized member of the cyclin family. It is highly conserved among eumetazoan species [1] , suggesting that Cyclin Y has important biological functions. In 2010, Liu et al. [2] found that Cyclin Y is essential for several developmental processes in Drosophila. Moreover, cyclin Y null mutant is homozygous lethal with most mutant animals arresting during pupal development. At the same time, another group reported that Cyclin Y is necessary for targeting presynaptic components to the axon in Caenorhabditis elegans [3] . An intriguing finding is that Cyclin Y is required in vivo for LRP6 phosphorylation, maternal Wnt signaling, and Wnt-dependent anteroposterior embryonic patterning in Xenopus [4] . The 14-3-3 proteins are a family of small acidic, dimeric proteins that appear to be present in all eukaryotic organisms. There are seven 14-3-3 isoforms in mammals: b, g, 1, h, s, t, and z. All 14-3-3 proteins are highly conserved, with 50% identity among amino acids both within and across species [5] . Although the 14-3-3 proteins have no detectable catalytic domain [6] , they are involved in the regulation of almost all biological processes via regulation of hundreds of interacting proteins. The vast majority of cellular-binding partners interact with 14-3-3 proteins in a phosphorylation-dependent manner [7] . Two canonical 14-3-3 binding motifs have been defined as RSXpSXP and RXXXpSXP (where R is arginine, S is serine, X is any amino acid, pS is phosphoserine, and P is proline). Phosphothreonine ( pT) could be replaced with pS [8, 9] . The different regulatory role of 14-3-3 proteins can be grouped into three major modes of action [5, 10, 11] : (i) Directed conformational changes in the target protein. The highly a-helical nature of the 14-3-3 proteins is rigid, which upon binding to target protein leads to deformation of the target protein with little or no change in the structure of the 14-3-3 dimer [11] . By this way, 14-3-3 binding can alter the intrinsic catalytic activity of the target protein, either inhibiting or augmenting its function; (ii) Masking. 14-3-3 Proteins act as masks to physically occlude sequence-specific or structural features of their targets, thus to modify the target protein localization [12] or to protect the target from other modifications such as dephosphorylation [13] ; (iii) Scaffolding. 14-3-3 Dimer can bridge two proteins together and serve as a phosphorylationdependent scaffold protein [14] .
Human Cyclin Y (CCNY) protein is composed of 341 amino acids, with the 143-249 amino acid residues forming a 'cyclin fold', a stack of five a-helices termed the cyclin box [1, 15] . Conventional cyclins require two cyclin folds for their activity; it is unknown how CCNY binds to and activates its kinase partner with only a single cyclin fold [1, 15] . We have previously reported that the interaction between CCNY and its kinase partner CDK14 requires the typical CDK-cyclinbinding domains, the 'PFTAIRE' motif in CDK14, and the cyclin-fold domain in CCNY. In addition, it also requires additional regions outside the cyclin box (85-136 aa and 244-341 aa) [16] , implying the involvement of other regulatory mechanisms. Data in the present paper demonstrated that the binding of 14-3-3 proteins to CCNY enhanced the association between CCNY and CDK14, adding a new layer of regulation of CCNY binding to its kinase partner.
Materials and Methods
Yeast two-hybrid assay The yeast two-hybrid screening and yeast two-hybrid interaction assays were carried out as described previously [17, 18] . A human adult brain LexA two-hybrid complementary DNA (cDNA) library (Clontech, Mountain View, USA) in which cDNA fragments inserted in pB42AD were used for two-hybrid screening. pGilda-CCNY (LexA-CCNY fusion) was used as a bait to screen the library. Saccharomyces cerevisiae strains used were EGY48 (MATa, trp1, ura3, his3, leu2, lexA op(Â6) -leu2) and CJY151 (MATa, his3, trp1, LexA op(Â6) -leu2, LexA op(Â8) -lacZ), which was generated by integrating the lacZ reporter and its upstream modulation sequence to the strain EGY48. The pGilda was used for the expression of LexA-tagged fusion proteins. The pB42AD was used for the expression of HA fusion proteins with the B42 activation domain under the control of GAL1 promoter. The pSH17-4 was a positive control plasmid for LexA-AD fusion protein.
The pRFHM1 was a negative control plasmid for expression of a LexA-human lamin C fusion protein. Filter assays for b-galactosidase activity were performed as described previously [19] . X-gal was used as a substrate. Colonies (2 mm diameter) on filters were frozen with liquid nitrogen for 1 min, then incubated with X-gal (334 mg/ml) at 308C.
Plasmid construction
For over-expression in HEK-293T cells, human CCNY open reading frame (ORF) was cloned into a pMYCN3 or pEGFPN3 vector, where a C-terminal Myc-tag or GFP-tag was fused to CCNY [20] . Human CDK14 ORF was cloned into a pEGFPN3 vector. Site-directed mutagenesis of CCNY was generated by polymerization chain reaction amplification using a mutagenesis kit (Strategene, Wilmington, USA). Human 14-3-31, b, h, or t ORF was cloned into a pcDNA3.1-N-Flag vector.
Cell culture All cells in this study were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum (Invitrogen, Carlsbad, USA.) and penicillin/streptomycin at 378C and 5% CO 2 . Cells were transfected by using Lipofectamine TM 2000 (Invitrogen) according to manufacturer's instruction. An equal amount of empty vectors was used as control in all experiments.
Co-immunoprecipitation and immunoblotting
Transiently transfected HEK-293T cells were collected 24 h post-transfection, and then lysed with 1%-Trition lysis buffer [50 mM Tris, pH 7.5, 150 mM NaCl, 1% TritonX-100, 1 mM EDTA, complete protease inhibitor cocktail (Roche, Basel, Switzerland), and PhosSTOP phosphatase inhibitor (Roche)]. The same amount of total proteins was incubated with anti-Myc beads for 3 h at 48C. After washing, the bound proteins were eluted by boiling the beads and separated on sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Antibodies used in the present study were anti-14-3-3b (SC-25276; Santa Cruz, Santa Cruz, USA); anti-FLAG (A2220; Sigma, St Louis, USA); anti-C-MYC (C3956; Sigma); and anti-GFP (11814460001; Roche).
Subcellular localization
Transfected HEK-293T cells were plated at a low confluency close to 30% on coverslips in a 12-well plate. Twenty-four hours later, the cells were washed with phosphate buffered saline (PBS) and fixed with 4% paraformaldehyde for 10 min at room temperature, and then washed with PBS. To visualize nuclei, the cells were stained with 1 mg/ml 4 0 , 6-diamidino-2-phenylindole (DAPI) for 5 min, and then washed with PBS. Coverslips were mounted and observed under a Zeiss confocal microscope.
Results

CCNY interacts with 14-3-3 proteins in vitro and in vivo
To identify CCNY-interacting proteins, a full-length human CCNY was used as a bait to screen a human brain Lex-A twohybrid library. In addition to CDK14, which has been shown to be a kinase partner activated by CCNY, four 14-3-3 isoforms (1, b, h, t) were also identified. Their interactions were further validated by direct yeast two-hybrid analysis. The yeast CJY151 co-transformed with pGilda-CCNY and pB42AD-14-3-3 plasmids grew well on SC Gal His 2 , Trp 2 , Leu 2 medium and showed b-galactosidase activity in 4-h incubation at 308C, confirming the CCNY-14-3-3 interaction in vitro (Fig. 1A) . To further verify the physical interaction of these proteins in vivo, a co-IP assay was performed by using mouse brain extracts. The mouse brain extracts were immunoprecipitated by an anti-14-3-3b antibody, and the presence of CCNY was investigated by western blotting. CCNY was clearly detected in the 14-3-3b immunoprecipitant, but not in that of IgG control (Fig. 1B) , confirming that CCNY interacted with 14-3-3 proteins in vivo.
Both N-and C-terminal regions of CCNY are required for 14-3-3 binding CCNY contains a single cyclin box domain (143 -243 aa), which is required for binding to CDK14, and long N-and C-terminal regions outside the cyclin box domain. To investigate the regions of CCNY that are necessary for interaction with 14-3-3 proteins, we constructed various deletion mutants of pGilda-CCNY for interaction analysis between CCNY and 14-3-3 proteins using a yeast two-hybrid system ( Fig. 2A) . The yeast strains harboring CCNY or CCNY mutants with 14-3-3b were incubated on leucine containing Cyclin Y interacts with 14-3-3 proteins media for b-galactosidase activity assay. Results showed that CCNY lacking 1-54 aa retained the ability to interact with 14-3-3b, but CCNY lacking 1-83 aa was unable to interact with 14-3-3b, suggesting that the 55-83 amino acid residues were required for 14-3-3 binding. Furthermore, CCNY lacking 311-341 aa in the C-terminus did not interact with 14-3-3b either, indicating that this region was also required for 14-3-3 binding (Fig. 2B) . We further examined the growth abilities of the yeast strains on leucine-depleting media. Interaction between CCNY and 14-3-3b resulted in Figure 1 . CCNY interacts with 14-3-3 proteins (A) Interaction between CCNY and four 14-3-3 isoforms (1, b, h, t) in a yeast two-hybrid system. The pGilda-CCNY and pB42AD-14-3-3 plasmids were co-transformed into CJY151. pSH17-4 containing LexA-AD fusion protein was used as a positive control. The interactions were analyzed using a b-galactosidase activity assay on SC Gal His Lysates from mouse brain were prepared and immunoprecipitated by mouse monoclonal anti-14-3-3b or IgG as a control. The immunoprecipitates were blotted with an anti-14-3-3b antibody or anti-CCNY antibody. The mouse brain lysates were probed with an anti-14-3-3b antibody as a loading control. and incubated at 308C for 3 days. Plasmid pSH17-4 containing a LexA-AD fusion was used as a positive control and pRFHM1 containing a LexA-human lamin C fusion was used as a negative control.
Cyclin Y interacts with 14-3-3 proteins growth of the yeast strains on Leu 2 media. The growth ability assay confirmed the results of b-galactosidase activity assay (Fig. 2C) . These data indicated that both N-and C-terminal regions outside the cyclin box were required for the interaction between CCNY and 14-3-3 proteins.
The Ser-100 and Ser-326 are crucial for the interaction between CCNY and 14-3-3 proteins The 14-3-3 proteins mostly bind to their ligands through pS/ pT motifs with a few exceptions [21] . We performed a co-IP assay to examine whether the interaction between CCNY and 14-3-3 proteins is phosphorylation-dependent. As shown in Fig. 3A , when the cell lysates were pre-treated with lambda protein phosphatase, Flag-14-3-3b was hardly pulled down by CCNY-Myc (Fig. 3A) , indicating that dephosphorylation would abolish 14-3-3 binding to CCNY. We then searched the N-and C-terminal regions of CCNY for 14-3-3 binding sites, and found four putative 14-3-3 binding sites at Thr-67, Ser-83, Ser-100, and Ser-326 (Fig. 3B) based on the two canonical 14-3-3 binding phosphopeptide motifs: RSXpSXP and RXXXpSXP.
To determine whether these predicted residues can provide docking sites for 14-3-3 proteins, we mutated the Thr and/or Ser residues to non-phosphorylatable Ala. Co-IP assay and western blotting revealed that T67A and S83A mutations did not affect the association of CCNY with 14-3-3b. However, the mutation S100A or S326A greatly reduced the association of CCNY with 14-3-3b. Double mutation of Ser-100 and Ser-326 completely abolished 14-3-3 binding with CCNY (Fig. 3C) , suggesting that the phosphorylation of CCNY at Ser-100 and Ser-326 was critical for 14-3-3 binding. Phosphorylation at Ser326 has been detected in both nuclear and cytoplasmic fractions [22, 23] . Our unpublished data also showed that Ser-100 and Ser-326 of CCNY were phosphorylated. Sequence alignment showed that the residues Ser-100 and Ser-326 were highly conserved among eumetazoans, from hydra to human (Fig. 3D) , suggesting that the interaction between CCNY and 14-3-3 proteins was evolutionary conserved.
Binding to 14-3-3 does not alter membrane localization of CCNY We next investigated the regulatory role of 14-3-3 binding in CCNY. In some cases, 14-3-3 proteins are implicated in regulating the subcellular localization of their target proteins by acting as a mask [6] . Ectopically expressed CCNY is enriched at the plasma membrane due to myristoylation at N-terminal Gly-2 [16] . We investigated whether 14-3-3 Cyclin Y interacts with 14-3-3 proteins binding will regulate the membrane localization of CCNY. The following plasmids were transfected: wild-type CCNY-GFP, S100A, S326A, or S100/326A mutants into HEK-293T cells, and their subcellular localizations were visualized by fluorescence confocal microscopy. All these mutants showed clear membrane-localization, similar to the wild-type CCNY (Fig. 4) , suggesting that 14-3-3 binding was not required for membrane localization of the CCNY.
Binding to 14-3-3 proteins enhances the association of a CCNY/CDK14 kinase complex Another important regulatory activity of 14-3-3 proteins is to alter the binding ability of the target proteins. We decided to examine whether 14-3-3 binding affects the interaction between CCNY and its kinase partner CDK14. In a co-IP assay, co-transfection of the 14-3-3 isoforms significantly increased the amount of CDK14-GFP pulled down by CCNY-Myc (Fig. 5A) , with the 14-3-3t isoform showing less effect on this association. Thus, 14-3-3 binding could enhance the association of a CCNY/CDK14 complex.
The 14-3-3 proteins can play two possible roles in mediating CCNY/CDK14 association. One is that 14-3-3 proteins could act as a scaffold to bridge the interaction between CCNY and CDK14, as 14-3-3 proteins have been proven to bind to CDK14 in our previous report [17] . Another one is that 14-3-3 binding might induce conformational changes in CCNY or CDK14, which could lead to a higher binding affinity. To address which one is true in this context, we performed co-IP assays. As shown in Fig. 5B , co-expression of 14-3-3b could increase the interaction between CCNY and wild-type CDK14 as well as between CCNY and 14-3-3 binding-deficient mutant CDK14 S119A (Fig. 5B) . However, the interaction between 14-3-3 binding-deficient mutant CCNY S100/326A and wild-type CDK14 could not be enhanced by ectopically expressed 14-3-3b (Fig. 5B) . If 14-3-3 proteins act as a scaffold, both 14-3-3 binding-deficient mutants CDK14 S119A and CCNY S100/326A should weaken the role of 14-3-3, whereas only CCNY S100/326A but not CDK14 S119A abolishes the function of 14-3-3 proteins in mediating CCNY/CDK14 association. Thus, binding with 14-3-3 probably induces conformational changes in CCNY, leading to a higher affinity binding with CDK14. Cyclin Y interacts with 14-3-3 proteins
Discussion
In the current study, four 14-3-3 isoforms (1, b, h, t) were identified as novel CCNY-interacting partners in a yeast two-hybrid screening. CCNY contains two functional 14-3-3 binding sites, Ser-100 and Ser-326, in which mutation of these two sites to the nonphosphorylatable Ala residues completely abrogated 14-3-3 binding to CCNY. We also found that ectopically expressed 14-3-3 proteins could enhance the association of a CCNY/CDK14 complex. 14-3-3 proteins can bind to CCNY as well as CDK14. It seems that only the association with CCNY contributes to promote CCNY/CDK14 interaction. Based on these observations, we proposed that 14-3-3 probably acts as a scaffold protein to mediate the association of CCNY and CDK14, and that binding with 14-3-3 may also induce conformational changes in CCNY, leading to a higher affinity binding with CDK14.
Cyclins are generally very different from each other in primary structure, but they all contain a similar tertiary structure of compact domain of five a-helices, termed cyclin box [24] . Conventional cyclins usually have two cyclin folds: the N-terminal fold is conserved and necessary for CDK binding and activation; and the C-terminal fold is required for the proper folding of the cyclin molecule [1] . The regulatory role of 14-3-3 proteins in CCNY presented here may provide a new mechanism by which CCNY binds to and activates its kinase partners with only a single cyclin fold. The CCNY protein harbors two docking sites for 14-3-3 proteins: ser-100 which is located to the N-terminal of the cyclin box, and Ser-326 which is located to the C-terminal. 14-3-3 Binding to CCNY probably exposes the cyclin box, thus allowing its access to the 'PFTAIRE' motif of CDK14. Furthermore, the two 14-3-3 binding sites on CCNY exist in all metazoans, indicating that the interaction between CCNY and 14-3-3 proteins is highly conserved in evolution. The 14-3-3 proteins are likely to play important regulatory roles in the full function of CCNY.
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